Recognitions by American Banker and CNET Reflect Outstanding Service Experience and Products TUSTIN, Calif.–(BUSINESS WIRE)–#PeopleHelpingPeople—SchoolsFirst Federal…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex…
GigNet Delivers Advanced Connectivity Solutions to the World Wide Technology Championship at Mayakoba, a PGA Tour Event Underway in Riviera Maya, Mexico
CANCUN, Mexico–(BUSINESS WIRE)–#Broadband–GigNet, a Digital Infrastructure Company that has completed an extensive fiber-optic broadband network from…
Best’s Market Segment Report: AM Best Revises Outlook on German Non-Life Insurance Segment to Negative
AMSTERDAM–(BUSINESS WIRE)–AM Best is revising its outlook on Germany’s non-life insurance segment to negative from stable.…
Societe Generale CEO Interview – Q3 2022 Results (Video)
PARIS–(BUSINESS WIRE)–Societe Generale, one of the largest European financial services groups, reports results for the third…
Pacific Prime Announces 2022 Scholarship Winner
HONG KONG–(BUSINESS WIRE)–Pacific Prime is excited to announce the winner of their 2022 Scholarship Program. Folorunso…
Beckley Psytech to Attend and Present at the Jefferies London Healthcare Conference – November 15-17, 2022
OXFORD, England–(BUSINESS WIRE)–Beckley Psytech Limited, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through…
Investing Platform Public Announces Global Launch
International investors can join the waitlist ahead of market rollouts in early 2023 NEW YORK–(BUSINESS WIRE)–Public.com,…
BenevolentAI to present at Jefferies Investor Conference in November
LONDON–(BUSINESS WIRE)–BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will…
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Innate will share preliminary results of the cohort evaluating lacutamab in Sezary syndrome patients post-mogamulizumab from…